Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.
Publication
, Journal Article
Pignone, M; Alberts, MJ; Colwell, JA; Cushman, M; Inzucchi, SE; Mukherjee, D; Rosenson, RS; Williams, CD; Wilson, PW; Kirkman, MS
Published in: Circulation
June 22, 2010
Duke Scholars
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
June 22, 2010
Volume
121
Issue
24
Start / End Page
2694 / 2701
Location
United States
Related Subject Headings
- United States
- Societies, Medical
- Risk Factors
- Platelet Aggregation Inhibitors
- Humans
- Dose-Response Relationship, Drug
- Diabetes Complications
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Aspirin
Citation
APA
Chicago
ICMJE
MLA
NLM
Pignone, M., Alberts, M. J., Colwell, J. A., Cushman, M., Inzucchi, S. E., Mukherjee, D., … Kirkman, M. S. (2010). Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Circulation, 121(24), 2694–2701. https://doi.org/10.1161/CIR.0b013e3181e3b133
Pignone, Michael, Mark J. Alberts, John A. Colwell, Mary Cushman, Silvio E. Inzucchi, Debabrata Mukherjee, Robert S. Rosenson, Craig D. Williams, Peter W. Wilson, and M Sue Kirkman. “Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.” Circulation 121, no. 24 (June 22, 2010): 2694–2701. https://doi.org/10.1161/CIR.0b013e3181e3b133.
Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Circulation. 2010 Jun 22;121(24):2694–701.
Pignone, Michael, et al. “Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.” Circulation, vol. 121, no. 24, June 2010, pp. 2694–701. Pubmed, doi:10.1161/CIR.0b013e3181e3b133.
Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Circulation. 2010 Jun 22;121(24):2694–2701.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
June 22, 2010
Volume
121
Issue
24
Start / End Page
2694 / 2701
Location
United States
Related Subject Headings
- United States
- Societies, Medical
- Risk Factors
- Platelet Aggregation Inhibitors
- Humans
- Dose-Response Relationship, Drug
- Diabetes Complications
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Aspirin